Regorafenib plus FOLFIRI with irinotecan dose escalated according to uridine diphosphate glucuronosyltransferase 1A1genotyping in previous treated metastatic colorectal cancer patients:study protocol for a randomized controlled trial.
Cheng-Jen MaTsung-Kun ChangHsiang-Lin TsaiWei-Chih SuChing-Wen HuangYung-Sung YehYu-Tang ChangJaw-Yuan WangPublished in: Trials (2019)
ClinicalTrials.gov, NCT03880877. Prospectively registered on 19 March 2019.